Prescriptive Infusion Algorithm (PIA) (NCT07215403)
Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)
🩺 Plain-English Summary (8th-Grade Level)
This study is being done to test a new way of delivering AB-1005 into the brain. The goal is to make the procedure easier and quicker to perform, while providing similar amounts of drug to the part of the brain that needs treatment. Technical (Stage 0) To test if the new delivery method (prefrontal surgical approach) can consistently deliver AB-1005 to the putamen using MRI monitoring. Technical (Stage 1) To test if the new delivery method (PIA-based infusion) can consistently deliver AB-1005 to the putamen using brain imaging by MRI. Technical (Stage 2) To confirm the new delivery method works without brain imaging by MRI, using standard operating room tools including brain imaging by CT. Safety (Stage 1 and 2) To assess the safety and tolerability of the new delivery method for AB-1005 up to 6 months after surgery
Who can join: Review the eligibility criteria below.
Location: University Hospitals Cleveland Medical Center — Cleveland, Ohio
Age range: 45 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- The Ohio State University Wexner Medical Center Neurological Surgery — Columbus, Ohio
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- Medical University of South Carolina — Charleston, South Carolina
📞 Contact the Study Coordinator
Phone: (919) 561-6210
Email: askfirst@askbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in PARKINSON DISEASE (Disorder)
- Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD) — Boulder, Colorado
- SwallowFIT Study in Parkinson's Disease — San Antonio, Texas
- Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation — Richardson, Texas
- Multicontext Approach for Cognitive Function in Parkinson Disease — St Louis, Missouri
- Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms — Cleveland, Ohio
Explore by condition: All PARKINSON DISEASE (Disorder) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.